Inmune Bio (INMB) Cash from Financing Activities (2018 - 2025)
Inmune Bio (INMB) posted Cash from Financing Activities of $67,000 for Q4 2025, compared with -$2.08 million a year earlier.
Powered by 
Analysis
Inmune Bio (INMB) Cash from Financing Activities (2018 - 2025) Analysis & Trends
For FY2025, Inmune Bio's Cash from Financing Activities came in at $27.61 million, up 51.6% from FY2024.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- In prior years, Inmune Bio's Cash from Financing Activities was $18.21 million in FY2024, -$4.23 million in FY2023, $729,000 in FY2022 (-99.2%) and $96.36 million in FY2021 (+303.3%).
- Quarterly Cash from Financing Activities has run from a low of -$2.5 million in Q4 2023 to a high of $52.94 million in Q3 2021 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Inmune Bio | 53.92 Mn | -38.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 67,000.00 |
| Jun 30, 2025 | 22.27 Mn |
| Mar 31, 2025 | 5.27 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | -2.50 Mn |
| Dec 31, 2023 | -2.50 Mn |
| Mar 31, 2022 | 729,000.00 |
| Sep 30, 2021 | 52.94 Mn |
| Jun 30, 2021 | 14.95 Mn |
| Mar 31, 2021 | 28.46 Mn |
| Sep 30, 2020 | 23.24 Mn |
| Jun 30, 2020 | 664,000.00 |
| Mar 31, 2020 | -9,000.00 |
| Jun 30, 2019 | 4.96 Mn |
| Mar 31, 2019 | 7.25 Mn |
| Mar 31, 2018 | 900,000.00 |
API Access
Inmune Bio Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();